Cargando…

ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology

The ASH Research Collaborative is a nonprofit organization established through the American Society of Hematology’s commitment to patients with hematologic conditions and the science that informs clinical care and future therapies. The ASH Research Collaborative houses 2 major initiatives: (1) the D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wood, William A., Marks, Peter, Plovnick, Robert M., Hewitt, Kathleen, Neuberg, Donna S., Walters, Sam, Dolan, Brendan K., Tucker, Emily A., Abrams, Charles S., Thompson, Alexis A., Anderson, Kenneth C., Kluetz, Paul, Farrell, Ann, Rivera, Donna, Gertzog, Matthew, Pappas, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2021
Materias:	Health Services and Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153041/ https://www.ncbi.nlm.nih.gov/pubmed/34673922 http://dx.doi.org/10.1182/bloodadvances.2021005902

Ejemplares similares

Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub
por: Wood, William A., et al.
Publicado: (2020)

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
por: Roeker, Lindsey E., et al.
Publicado: (2023)

Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2023)

Outcomes of Patients with Hematologic Malignancies and COVID-19 Infection: A Report from the ASH Research Collaborative Data Hub
por: Wood, William A., et al.
Publicado: (2020)

Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL
por: Tam, Constantine, et al.
Publicado: (2023)

Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology
por: Hicks, Lisa K., et al.
Publicado: (2021)

Mortality and guideline‐directed medical therapy in real‐world heart failure patients with reduced ejection fraction
por: McCullough, Peter A., et al.
Publicado: (2021)

Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint
por: Curtis, Melissa D., et al.
Publicado: (2018)

Clinical Predictors of Outcome in Adult Patients with Acute Leukemias and Myelodysplastic Syndrome and COVID-19 Infection: Report from the American Society of Hematology Research Collaborative (ASH RC) Data Hub
por: Desai, Pinkal, et al.
Publicado: (2021)

Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016–2018
por: Grabich, Shannon, et al.
Publicado: (2022)

Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review
por: Ahmad, Nadia N., et al.
Publicado: (2021)

Real-world treatment patterns, healthcare resource utilisation and costs in patients with systemic lupus erythematosus treated with belimumab: a retrospective analysis of claims data in the USA
por: Bell, Christopher F, et al.
Publicado: (2020)

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
por: Chien, Kelly S., et al.
Publicado: (2023)

Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015
por: Hammond, Edward R, et al.
Publicado: (2021)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Coping in caregivers of patients with hematologic malignancies undergoing hematopoietic stem cell transplantation
por: Amonoo, Hermioni L., et al.
Publicado: (2022)

Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015
por: Jiang, Miao, et al.
Publicado: (2021)

Rapid real‐world data analysis of patients with cancer, with and without COVID‐19, across distinct health systems
por: Hwang, Clara, et al.
Publicado: (2021)

Influence of participant and reviewer characteristics in application scores for a hematology research training program
por: Vesely, Sara K., et al.
Publicado: (2023)

The quick pivot: Capturing real world modifications for the re-implementation of an early psychosis program transitioning to virtual delivery
por: Tempelaar, Wanda, et al.
Publicado: (2023)

What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients
por: Barata, Anna, et al.
Publicado: (2023)

Outcomes before and after providing interdisciplinary hematology and pulmonary care for children with sickle cell disease
por: Zeno, Rachel N., et al.
Publicado: (2022)

Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data
por: Maignan, Kathleen, et al.
Publicado: (2022)

Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective
por: Azoulay, Laurent
Publicado: (2022)

Code status transitions in patients with high-risk acute myeloid leukemia
por: Abrams, Hannah R., et al.
Publicado: (2022)

Orthopedic Coordinated Registry Network (Ortho-CRN): advanced infrastructure for real-world evidence generation
por: Gressler, Laura Elisabeth, et al.
Publicado: (2022)

Atrial fibrillation diagnosis in patients with single- and dual chamber ICD devices in England: a real-world cohort study
por: Davidson, J A, et al.
Publicado: (2023)

Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients
por: Janssen, Carly A., et al.
Publicado: (2017)

Assessment of the effects of methodological choice in continuity of care research: a real-world example with dyslipidaemia cohort
por: Choo, Eunjung, et al.
Publicado: (2021)

Evaluating Pneumonitis Incidence in Patients with Non–small Cell Lung Cancer Treated with Immunotherapy and/or Chemotherapy Using Real-world and Clinical Trial Data
por: Liu, Qi, et al.
Publicado: (2023)

Association of Race, Ethnicity, Age and Socioeconomic Status with Access to Virtual Visits within the Brigham & Women's Hospital Division of Hematology during the COVID-19 Pandemic
por: Kwarteng-Siaw, Miriam, et al.
Publicado: (2021)

Non‐Invasive prenatal testing with rolling circle amplification: Real‐world clinical experience in a non‐molecular laboratory
por: Saidel, Matthew L., et al.
Publicado: (2023)

Challenges of diabetes prevention in the real world: results and lessons from the Melbourne Diabetes Prevention Study
por: Dunbar, James A, et al.
Publicado: (2015)

Real-World Challenges of Promoting Community Health
por: Tucker, Pattie, et al.
Publicado: (2007)

Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis
por: Raghunandan, Sharmila, et al.
Publicado: (2023)

Real‐World Clinical and Economic Outcomes in Selected Immune‐Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Zheng, Ying, et al.
Publicado: (2021)

Artificial intelligence-enabled screening for diabetic retinopathy: a real-world, multicenter and prospective study
por: Zhang, Yifei, et al.
Publicado: (2020)

Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier’s gangrene
por: Yang, Jeff Yufeng, et al.
Publicado: (2020)

COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals
por: Singh, Ashima, et al.
Publicado: (2021)

The inclusion of real world evidence in clinical development planning
por: Martina, Reynaldo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0pqfdtfvrqbt10m7126qifu58l